Skip to main content
Clinical Trials/ACTRN12621000029897
ACTRN12621000029897Not yet recruiting未知

Effect of probiotic supplementation on composition of fecal microbiota in children with autism spectrum disorder-a pilot randomized controlled trial

Perth children hospital, Child and Adolescent health services0 sites40 target enrollmentStarted: January 14, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
2 Years to 5 Years (—)
Sex
All

Inclusion Criteria

  • (1)Children Age: 2–5 years. (2) Confirmed diagnosis of ASD based on DSM-5 criteria.

Exclusion Criteria

  • (1) Major congenital anomalies (2) Epilepsy syndromes, significant sensory impairment (e.g., blindness, deafness), neonatal hypoxic ischemic encephalopathy requiring therapeutic cooling (3) Coeliac disease, inflammatory bowel disease (4) Use of probiotics for 4 weeks in the 90 days before enrolment (5) Current or recent (within 4 weeks before enrolment) exposure to antibiotics, chemotherapy or immunosuppressant agents, or laxatives. (6) Prosthetic devices including heart valves (7) Confirmed HIV, Hepatitis B, and/or Hepatitis C. (8) Known allergy to probiotics (9) Special diets(10) Cows’ milk protein allergy, food allergy, or conditions such as atopic dermatitis, or eczema.

Investigators

Sponsor
Perth children hospital, Child and Adolescent health services

Similar Trials

Effect of Probiotic supplementation on gut... | Clinical Trial